ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 86 filers reported holding ANTHERA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,000 | 0.0% | 1,195 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | -75.0% | 1,195 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | -33.3% | 1,195 | -40.2% | 0.00% | – |
| Q2 2016 | $6,000 | -14.3% | 2,000 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | +40.0% | 2,000 | +100.0% | 0.00% | – |
| Q4 2015 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
| Q3 2015 | $6,000 | -14.3% | 1,000 | -50.0% | 0.00% | – |
| Q2 2014 | $7,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 2,535,564 | $7,835,000 | 4.00% |
| ProQuest Associates IV LLC | 1,900,000 | $5,871,000 | 2.39% |
| Abingworth LLP | 437,994 | $1,349,000 | 1.41% |
| Hilltop Park Associates LLC | 75,000 | $232,000 | 0.97% |
| Broadfin Capital, LLC | 1,154,674 | $3,568,000 | 0.35% |
| Perceptive Advisors | 1,492,156 | $4,611,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 300,000 | $927,000 | 0.16% |
| Rock Springs Capital Management LP | 450,000 | $1,391,000 | 0.10% |
| WEXFORD CAPITAL LP | 145,622 | $450,000 | 0.08% |
| BOOTHBAY FUND MANAGEMENT, LLC | 15,960 | $49,000 | 0.02% |